Survival benefit of thermal ablation combined with chemotherapy for the treatment of stage IV nonsmall cell lung cancer: a propensity-matched analysis
CONCLUSION: TA plus chemotherapy is a potential treatment option for Stage-IV NSCLC, especially for patients aged 70 or older with tumor size ≤3 cm.PMID:35164638 | DOI:10.1080/02656736.2022.2038281
Source: International Journal of Hyperthermia - Category: Internal Medicine Authors: Hao Yang Mengqi Li Tonghua Mei Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Epidemiology | Internal Medicine | Lung Cancer | Men | Non-Small Cell Lung Cancer | Statistics